Early research (Phase 1)WithdrawnNCT00445757What this trial is testingStereotactic Radiation Therapy in Treating Patients With Kidney TumorsWho this might be right forKidney Cancer Case Comprehensive Cancer Center
Not applicableWithdrawnNCT02061605What this trial is testingFirst-in-Human Safety Study Of Laser Tissue Welding For Surtureless Laparoscopic Partial NephrectomyWho this might be right forBenign Renal TumorsMalignant Renal Tumors Laser Tissue Welding, Inc.
Testing effectiveness (Phase 2)Study completedNCT00005056What this trial is testingBryostatin 1 In Treating Patients With Progressive Kidney CancerWho this might be right forKidney Cancer Cancer Research UK
Early research (Phase 1)Looking for participantsNCT06553339What this trial is testingHS-10516 in Patients With VHL Syndrome Associated TumorsWho this might be right forVon Hippel Lindau-Deficient Clear Cell Renal Cell Carcinoma Jiangsu Hansoh Pharmaceutical Co., Ltd. 60
Early research (Phase 1)Study completedNCT02014636What this trial is testingSafety and Efficacy Study of Pazopanib and MK 3475 in Advanced Renal Cell Carcinoma (RCC; KEYNOTE-018)Who this might be right forCarcinoma, Renal Cell Novartis Pharmaceuticals 42
Early research (Phase 1)Study completedNCT03556046What this trial is testing89Zr-girentuximab ) Dosimetry in CCRC Study - ZIR-DOSEWho this might be right forClear Cell Renal Carcinoma Radboud University Medical Center 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT03474497What this trial is testingUCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint BlockadeWho this might be right forNon Small Cell Lung CancerMetastatic MelanomaMetastatic Renal Cell Carcinoma+1 more Megan Daly, MD 18
Testing effectiveness (Phase 2)Ended earlyNCT02495103What this trial is testingVandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell CarcinomaWho this might be right forRenal Cell CarcinomaHereditary LeiomyomatosisRenal Cell Cancer National Cancer Institute (NCI) 7
Early research (Phase 1)Study completedNCT00001383What this trial is testingA Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833Who this might be right forBreast CancerCancerCarcinoma, Renal Cell+2 more National Cancer Institute (NCI) 52
Early research (Phase 1)Study completedNCT01522820What this trial is testingVaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsWho this might be right forAnaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more Roswell Park Cancer Institute 18
Testing effectiveness (Phase 2)Study completedNCT00002673What this trial is testingImmunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell TransplantationWho this might be right forCancer Fred Hutchinson Cancer Center 30
Early research (Phase 1)Study completedNCT00003107What this trial is testingInterleukin-12 in Treating Patients With Hematologic Cancers or Solid TumorsWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more Indiana University
Early research (Phase 1)Ended earlyNCT05861947What this trial is testingClinical Trial of AUR106 in Patients With Relapsed Advanced MalignanciesWho this might be right forRelapseAdvanced Malignant NeoplasmNon Small Cell Lung Cancer+5 more Aurigene Discovery Technologies Limited 21
Early research (Phase 1)Looking for participantsNCT07369505What this trial is testingSapu003 in Advanced mTOR-sensitive Solid TumorsWho this might be right forBreast Cancer MetastaticRenal Cell Carcinoma (RCC)Neuroendocrine Tumors+2 more SAPU NANO (US) LLC 27
Testing effectiveness (Phase 2)Study completedNCT00003105What this trial is testingCombination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder CancerWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter Memorial Sloan Kettering Cancer Center 30
Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT04561362What this trial is testingStudy BT8009-100 in Subjects With Nectin-4 Expressing Advanced MalignanciesWho this might be right forUrinary Bladder NeoplasmTriple Negative Breast NeoplasmsHormone Receptor Positive, HER2-negative Neoplasms+5 more BicycleTx Limited 329
Early research (Phase 1)Active Not RecruitingNCT04483778What this trial is testingB7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young AdultsWho this might be right forPediatric Solid TumorGerm Cell TumorRetinoblastoma+14 more Seattle Children's Hospital 68
Early research (Phase 1)Study completedNCT02035358What this trial is testingImmunotherapy Study for Metastatic Renal Cell CancerWho this might be right forMetastatic Renal Cell CarcinomaMetastatic Clear-cell Renal CancerRecurrent Renal Cell Carcinoma+2 more NewLink Genetics Corporation 18
Early research (Phase 1)Study completedNCT01155258What this trial is testingTemsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsWho this might be right forExtensive Stage Small Cell Lung CancerHereditary ParagangliomaMale Breast Cancer+45 more University of Southern California 19